Standing out in the field of IgY Immunotechnology

  • Home
    Home A full collection of all the Research Archive entries.
  • Years
    Years Sort entries by year.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Archives
    Archives Contains a list of research entries that were created previously.

Avian Influenza Vaccination in Chickens and Pigs with Replication-Competent Adenovirus–Free Human Recombinant Adenovirus 5*

Posted by on in 2010
  • Font size: Larger Smaller
  • Hits: 3525
  • Print

Haroldo ToroCa, Frederik W. van Ginkela, De-chu C. Tangb, Bettina Schemeraa, Soren Rodninga, and Joseph Newtona  2010, Avian Diseases 54(s1): 224-231. 

aDepartment of Pathobiology, 264 Greene Hall, Auburn University, AL 36849

bVaxin Inc., 1500 1st Avenue North, Birmingham, AL 35203


Protective immunity to avian influenza (AI) virus can be elicited in chickens by in ovo or intramuscular vaccination with replication-competent adenovirus (RCA)-free human recombinant adenovirus serotype 5 (Ad5) encoding AI virus H5 (AdTW68.H5) or H7 (AdCN94.H7) hemagglutinins. We evaluated bivalent in ovovaccination with AdTW68.H5 and AdCN94.H7 and determined that vaccinated chickens developed robust hemagglutination inhibition (HI) antibody levels to both H5 and H7 AI strains. Additionally, we evaluated immune responses of 1-day-old chickens vaccinated via spray with AdCN94.H7. These birds showed increased immunoglobulin A responses in lachrymal fluids and increased interleukin-6 expression in Harderian gland–derived lymphocytes. However, specific HI antibodies were not detected in the sera of these birds. Because pigs might play a role as a “mixing vessel” for the generation of pandemic influenza viruses we explored the use of RCA-free adenovirus technology to immunize pigs against AI virus. Weanling piglets vaccinated intramuscularly with a single dose of RCA-free AdTW68.H5 developed strong systemic antibody responses 3 wk postvaccination. Intranasal application of AdTW68.H5 in piglets resulted in reduced vaccine coverage, i.e., 33% of pigs (2/6) developed an antibody response, but serum antibody levels in those successfully immunized animals were similar to intramuscularly vaccinated animals.

The HRP-Goat anti-Chicken IgA used in this study is available from Gallus Immunotech.


Last modified on